EichorEICHOR
Study identifier: NCT05610319 Synced from ClinicalTrials.gov · August 05, 2026
● Active Not Recruiting

Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial

Condition: Diabetic Macular Edema  ·  Sponsor: McMaster University

PhasePhase 4
Planned participants446
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study will assess a pragmatic, treat and extend regimen of faricimab against the standard of a fixed dosing regimen.

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (46)

Retinal Consultants Medical Group Inc.Modesto, California, United States
Vitreo-Retina Medical GroupSacramento, California, United States
University Retina and Macula AssociatesOak Forest, Illinois, United States
Eye Associates of Northeast Louisiana Dba Haik Humble Eye CenterWest Monroe, Louisiana, United States
Mississippi Retina AssociatesJackson, Mississippi, United States
Austin Retina AssociatesAustin, Texas, United States
Retina Consultants of TexasBeaumont, Texas, United States
Retina & Vitreous of TexasBellaire, Texas, United States
Retina Consultants of Houston, dba Retina Consultants of TexasBellaire, Texas, United States
Valley Retina InstituteMcAllen, Texas, United States
Retina Consultants of Houston, dba Retina Consultants of TexasSan Antonio, Texas, United States
Eye Clinic Albury WodongaAlbury, New South Wales, Australia

+ 34 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →